Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective Janus kinase 1 Inhibitor, after Short-term Treatment of Rheumatoid Arthritis: Results of Two randomized Phase IIA Trials
Arthritis Rheumatol. 2017 Oct;69(10):1949-1959. doi: 10.1002/art.40186